$1.34
-0.07-4.96%
Last update: Nov 5, 3:41 PM
ProQR Therapeutics NV
PRQRNASDAQ
The average analyst price target for ProQR Therapeutics is $8, 497.0% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $2 to $14. The latest change came on Oct 1, 2026, when HC Wainwright & Co. lowered its price target on ProQR Therapeutics from $12 to $8 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
